These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Brain function in Duchenne muscular dystrophy. Anderson JL; Head SI; Rae C; Morley JW Brain; 2002 Jan; 125(Pt 1):4-13. PubMed ID: 11834588 [TBL] [Abstract][Full Text] [Related]
9. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
10. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy. Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761 [TBL] [Abstract][Full Text] [Related]
11. Altered release and uptake of gamma-aminobutyric acid in the cerebellum of dystrophin-deficient mice. Pereira da Silva JD; Campos DV; Nogueira-Bechara FM; Stilhano RS; Han SW; Sinigaglia-Coimbra R; Lima-Landman MTR; Lapa AJ; Souccar C Neurochem Int; 2018 Sep; 118():105-114. PubMed ID: 29864448 [TBL] [Abstract][Full Text] [Related]
12. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models. van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492 [TBL] [Abstract][Full Text] [Related]
13. Altered Synaptic Transmission and Excitability of Cerebellar Nuclear Neurons in a Mouse Model of Duchenne Muscular Dystrophy. Kreko-Pierce T; Pugh JR Front Cell Neurosci; 2022; 16():926518. PubMed ID: 35865113 [TBL] [Abstract][Full Text] [Related]
14. GABA(A) receptor expression and inhibitory post-synaptic currents in cerebellar Purkinje cells in dystrophin-deficient mdx mice. Kueh SL; Head SI; Morley JW Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):207-10. PubMed ID: 17941889 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy. Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083 [TBL] [Abstract][Full Text] [Related]
16. Why is early-onset atrial fibrillation uncommon in patients with Duchenne muscular dystrophy? Insights from the mdx mouse. Nguyen MN; Hooper C; Stefanini M; Vrellaku B; Carnicer R; Wood MJ; Simon JN; Casadei B Cardiovasc Res; 2024 Apr; 120(5):519-530. PubMed ID: 38270932 [TBL] [Abstract][Full Text] [Related]
17. Abnormal dysbindin expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy. Sillitoe RV; Benson MA; Blake DJ; Hawkes R J Neurosci; 2003 Jul; 23(16):6576-85. PubMed ID: 12878699 [TBL] [Abstract][Full Text] [Related]